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Inhibition of Small Conductance
Calcium-Activated Potassium (SK)
Channels Prevents Arrhythmias in
Rat Atria During β-Adrenergic and
Muscarinic Receptor Activation
Lasse Skibsbye1, Anne K. Bengaard1, A. M. Uldum-Nielsen1, Kim Boddum1,
Torsten Christ2 and Thomas Jespersen1*
1 Cardiac Physiology Laboratory, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of
Copenhagen, Copenhagen, Denmark, 2 Department of Experimental Pharmacology and Toxicology, University Medical
Center Hamburg-Eppendorf, DZHK: German Centre for Cardiovascular Research, Hamburg, Germany
Sympathetic and vagal activation is linked to atrial arrhythmogenesis. Here we
investigated the small conductance Ca2+-activated K+ (SK)-channel pore-blocker N-
(pyridin-2-yl)-4-(pyridine-2-yl)thiazol-2-amine (ICA) on action potential (AP) and atrial
fibrillation (AF) parameters in isolated rat atria during β-adrenergic [isoprenaline (ISO)]
and muscarinic M2 [carbachol (CCh)] activation. Furthermore, antiarrhythmic efficacy of
ICA was benchmarked toward the class-IC antiarrhythmic drug flecainide (Fleca). ISO
increased the spontaneous beating frequency but did not affect other AP parameters. As
expected, CCh hyperpolarized resting membrane potential (−6.2 ± 0.9 mV), shortened
APD90 (24.2 ± 1.6 vs. 17.7 ± 1.1 ms), and effective refractory period (ERP; 20.0 ± 1.3
vs. 15.8 ± 1.3 ms). The duration of burst pacing triggered AF was unchanged in
the presence of CCh compared to control atria (12.8 ± 5.3 vs. 11.2 ± 3.6 s), while
β-adrenergic activation resulted in shorter AF durations (3.3 ± 1.7 s) and lower AF-
frequency compared to CCh. Treatment with ICA (10 µM) in ISO -stimulated atria
prolonged APD90 and ERP, while the AF burden was reduced (7.1± 5.5 vs. 0.1± 0.1 s).
In CCh-stimulated atria, ICA treatment also resulted in APD90 and ERP prolongation and
shorter AF durations. Fleca treatment in CCh-stimulated atria prolonged APD90 and ERP
and abbreviated the AF duration to a similar extent as with ICA. Muscarinic activated
atria constitutes a more arrhythmogenic substrate than β-adrenoceptor activated atria.
Pharmacological inhibition of SK channels by ICA is effective under both conditions and
equally efficacious to Fleca.
Keywords: atrial fibrillation, SK channels, parasympathetic and sympathetic activation, β-adrenergic and
muscarinic activation, action potential recordings
Abbreviations: aERP, atrial effective refractory period; AF, atrial fibrillation; AP, action potential; APD, action
potential duration; CCh, carbachol; Fleca, flecainide; ICA, N-(pyridine-2-yl)-4-(pyridine-2-yl)thiazol-2-amine; ISO,
isoprenaline (isoproterenol); MAP, monophasic action potential; RMP, resting membrane potential; SK, small conductance
Ca2+-activated K+.
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INTRODUCTION
Atrial fibrillation is the most prevalent cardiac arrhythmia,
associated with increased cardiac morbidity and mortality
(Andrade et al., 2014; Jalife and Kaur, 2015; Walfridsson et al.,
2015). Due to inadequate efficacy and adverse events of current
treatments, there exists a high unmet medical need for efficacious
and safe antiarrhythmic drug (AAD) therapy. However, in order
to find and exploit potential new AF targets, a more thorough
mechanistic understanding of arrhythmogenesis and progression
of AF is needed (Roy et al., 2000; Ravens et al., 2013; Wettwer
et al., 2013).
Well-balanced autonomic nervous regulation is important
for adjusting and upholding proper cardiac electrophysiology.
However, at the same time, increased activity of both vagal and
sympathetic activation and autonomic imbalance is believed
to trigger and maintain supraventricular arrhythmias such as
AF (Chen et al., 2014; Heijman et al., 2016; Hou et al., 2016;
Östenson et al., 2017). Furthermore, autonomic receptors have
been described as an efficacious clinical target for interventional
anti-AF therapy (Linz et al., 2014). Autonomic nerves exert
stimulatory or inhibitory effects via adrenergic endogenous
neurotransmitter norepinephrine (NE) and muscarinic
acetylcholine (ACh) receptors, respectively (Christ et al., 2014).
Sympathetic nerves exert their effect through various α- and
especially β-adrenergic receptor (β-AR) subtypes. β1 receptors,
activating through cAMP and phosphorylation by protein kinase
A (PKA), have a profound effect on both calcium handling
and electrophysiology of atrial and ventricular cardiomyocytes
(Brodde et al., 2001; Volders, 2010). The cholinergic muscarinic
receptor includes M1−5 subtypes, with type-2 muscarinic
subtype (M2) highly expressed in the atria, SA- and AV-node
(Brodde et al., 2001; Linz et al., 2014). The cardiac M2 receptor
is an inhibitory Gαi subtype, activating IK,ACh, composed of
Kir3.1 (GIRK1) and Kir3.4 (GIRK4) subunits (Krapivinsky et al.,
1995). Activation of IK,ACh results in RMP hyperpolarization,
abbreviated atrial APD, and effective refractory period (Shimizu
et al., 1994; Wang et al., 2013).
Several studies have reported that the voltage-insensitive SK
channel constitutes a potential atrial selective target for AF
treatment (Xu et al., 2003; Tuteja et al., 2005; Ozgen et al.,
2007; Li et al., 2009; Diness et al., 2010, 2011). In the heart,
SK channels are found predominantly expressed in the atria
in several species, including rats and humans (Diness et al.,
2010; Skibsbye et al., 2014). Pharmacological blockage of SK
channels in acutely induced AF animal models, ranging from rat
to horse, has shown profound antiarrhythmic properties (Diness
et al., 2010, 2015; Haugaard et al., 2015; Skibsbye et al., 2015).
Furthermore, studies in human atrial trabeculae muscle from
patients in sinus rhythm (SR) reported SK channels to participate
in atrial repolarization and that pharmacological SK channel
blockage prolongs APD and refractoriness, and depolarize the
atrial RMP (Skibsbye et al., 2014).
When investigating the electrophysiological properties
during AF, it is challenging to obtain accurate intracellular
voltage potential measurements due to shivering and ridged
movement of the atrial muscle. However, recently, we developed
an ex vivo rat atrial model, using explanted beating atria, in
which transmembrane AP measurements can be recorded
continuously at initiation and during episodes of AF without
loss of intracellular recording (Skibsbye et al., 2015). Compared
to baseline AP stimulation, recordings during paroxysmal and
persistent tachy-arrhythmias revealed the minimal diastolic
(take-off) potential to be depolarized ≈10–15 mV and AP
amplitude, as well as upstroke velocity, to be drastically reduced
as a consequence of increased sodium channel inactivation at
depolarized potentials. This technique thereby constitutes a
highly interesting model for addressing AP parameter changes
following muscarinic and β-AR stimulation in the context of
atrial arrhythmias and a utility for mechanistically understanding
the electrophysiological effects following pharmacological
interventions.
In the present study, we pursue two objectives: (i) investigate
the acute effect on electrophysiological parameters following
sympathetic and parasympathetic pharmacological activation
in the context of arrhythmia and (ii) benchmarking the
antiarrhythmic efficacy of the small molecule tool compound
ICA, which is a pore-blocker of SK channels, with a relatively high
selectivity over other cardiac ion channels (Skibsbye et al., 2014)
toward Fleca, a classical class IC sodium channel inhibitor used
for rhythm control in AF treatment (Apostolakis et al., 2013) in
this mechanistic AF model.
MATERIALS AND METHODS
Experiments were performed under a license from the Danish
Ministry of Justice (License No. 2012-15-2934) and in accordance
with the Danish Guidelines for Animal Experiments according to
the European Commission Directive 86/609/EEC.
Microelectrode Measurement of Rat
Right Atrium
Adult male Sprague Dawley (Crl:SD) rats (Taconic, Cologne,
Germany) weighing between 345 and 575 g were used. All
experiments were conducted using a refined AF model of isolated
rat right atrium described recently (Skibsbye et al., 2015). The
isolated rat right atrium was placed in a Steiert papillary muscle
bath (Hugo Sachs Harvard Apparatus GmbH, March, Germany)
and perfused with Tyrode’s solution at 37◦C contain (in mM):
NaCl 118.1, KCl 4.0, CaCl2 1.8, MgCl2 1.0, NaH2PO3 24.9,
and D-glucose 11.0, bubbled with 95% O2 and 5% CO2. Atrial
APs were recorded with regular sharp capillary borosilicate
glass microelectrodes (Warner capillary glass, Harvard Apparatus
UK), pulled on a Sutter Instrument Co. Model P-97). Recording
electrodes acquired a tip resistance of 10–30 M when filled with
3.0 M KCl. The AP recordings were obtained with acquisition
software LabChart 7 Pro (AD Instruments, Sydney, Australia).
β-Adrenergic and Muscarinic Receptor
Activation
A graphic overview of the experimental setup is given in
Figure 1: atrial pacing was performed at double threshold
current (rheobase; usually 0.01–0.03 mA at the beginning of the
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FIGURE 1 | Flowchart. Graphic overview of the experimental design. After mounting of the right atrium in an organ bath and initiation of stimulated pacing, all
experiments were allowed to stabilize for 30 min. Experiments were divided into three randomized sub-studies. (Top panel) Basal characterization of AP parameters
without any premedication or antiarrhythmic treatment followed by induction of consecutive runs of AF by programmed atrial burst pacing. (Middle panel) Baseline
AP recordings followed by pre-treatment with [ISO], AP characterization, and AF induction followed by antiarrhythmic treatment with [ICA]. (Lower panel) Baseline
AP recordings followed by pre-treatment with [CCh], AP characterization, and AF induction before antiarrhythmic treatment with either [ICA], [Fleca], or [vehicle] with
the purpose to benchmark the antiarrhythmic efficacy between the two drugs in the muscarinic activated atria.
experiment and before every aERP measurement) with a stimulus
duration (pulsewidth) of 2 ms. Following electrode impalement
and satisfactory baseline AP recordings, the right atrium was
allowed to stabilize for 30 min. Inclusion criteria for satisfactory
AP recordings were RMP ≈ −75 mV and amplitude ≈ 85 mV.
Of note, the success rate for obtaining stable impalements in the
ISO-treated atria was low due to rigorously beating, disrupting
the seal. Following a 15 min baseline recording, the atrium was
exposed to either 1 µM ISO or 1 µM CCh or Ringer without
drugs (Basal). Under control condition, the isolated rat right
atrium had a spontaneous beating frequency of 3.5–4.5 Hz. Thus,
in order to pace above the intrinsic rate, all experiments (besides
those with ISO application) were performed at a 5 Hz pacing
frequency. ISO increased the spontaneous atrial rate, wherefore
these experiments were performed at 8 Hz pacing frequency.
After 30 min of superfusion with ISO 1 µM or CCh 1 µM
either of the test compounds [ICA 10 µM, Fleca 1 µM or vehicle
dimethyl sulfoxide (DMSO)] were applied to the buffer.
Atrial Effective Refractory Period
Measurement
Atrial effective refractory period measurements were performed
using an S1–S2 stimulation protocol, by decreasing the
S1–S2 interval by 2 ms increments with aERP defined as the
longest S1–S2 interval, which was unable to initiate an extra
S2-mediated AP.
Arrhythmia Induction
Atrial fibrillation was induced by a burst pacing protocol of
50 Hz using double rheobase voltage threshold for approximately
1 s repeated up to five times, depending on whether the burst
initiated an arrhythmia or not. When an arrhythmia was initiated,
stimulation was stopped until the arrhythmia spontaneously
reverted into SR or until the duration of arrhythmia lasted more
than 120 s. If the arrhythmia lasted more than 120 s, electrical
cardioversion was performed by single bursts of high-voltage
stimulation. The burst pacing induction protocol was applied in
the presence of ISO or CCh or basal stimulation 20–25 min after
application and after 30 min incubation with either ICA, Fleca,
or DMSO, serving as time-matched control (TMC). AF duration
was calculated as mean of all consecutive arrhythmic periods
following burst pacing, including zero counts when there was no
AF induction.
Chemicals
The compounds applied were of analytical grade with CCh
(carbamoylcholine chloride), ISO (ISO hydrochloride), and
Fleca (Fleca acetate) acquired from Sigma-Aldrich (Steinheim,
Germany). ICA was synthesized at NeuroSearch A/S (Ballerup,
Denmark). CCh and ISO were dissolved in Milli Q water, whereas
ICA and Fleca were dissolved in DMSO (anhydrous ≥ 99.9%).
Data and Statistical Analysis
Data acquisition was performed using LabChart 7-Pro software
(ADInstrument, Dunedin, New Zealand). For data analysis and
drawings, GraphPad Prism 6 software (GraphPad Software, San
Diego, CA, United States) was used. All data are presented as
mean± standard error of the mean (SEM). For calculations of AP
parameters, 10 consecutive APs were averaged. In all statistical
analyses, the level of significance was 95% confidence interval,
which means p-values < 0.05 were considered statistically
significant. For statistical analysis, two-tailed Student’s paired
t-test was applied to data in Figures 3, 4. One-way analysis of
variance (ANOVA) was applied to data in Figure 2. Two-way
ANOVA with Bonferroni post hoc test for multiple comparisons
was applied to data in Figures 5–7. Statistical analysis of
antiarrhythmic efficacy between Fleca and ICA was done using
Student’s unpaired t-test.
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FIGURE 2 | Isoprenaline and carbachol (CCh) effects on frequency and AF duration. Recordings in the presence of no activators (basal, A), [ISO] (β-adrenergic, C),
and [CCh] (muscarinic, E) activation. Burst pacing of the isolated right atrium leads to AF episodes of various lengths, all reverting spontaneously back to SR. Short
(1–2 s) runs of AF are displayed to exemplify both initiation and termination of AF. (B,D,F) Diary plots of beating rate (1000 beats) from representative experiments,
depicting the frequency during the induction and the free run of an arrhythmia before reverting back to SR. (G) AP frequencies in the entire group (mean ± SEM).
(H) AF duration in the absence of [ISO] or [CCh] (basal) or in the presence either [CCh] or [ISO]. Statistical analysis was done using one-way ANOVA, comparing
basal, CCh, and ISO. ∗p < 0.05.
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FIGURE 3 | Electrophysiological effects of [ISO]. (A) Diary plot depicting the effect of β-adrenergic activation on the pacemaker frequency (after application of [ISO] in
an isolated rat right atrium). An immediate increase in intrinsic beating frequency was observed shortly after application of [ISO] to the perfusion buffer. After a
transient peak, the frequency was maintained over time. (B) Bar graph shows the mean values ± SEM (n = 5) during basal intrinsic frequency and after [ISO]
application. The effect of β-adrenergic activation on AP parameters (n = 9): (C) the resting membrane potential (RMP), (D) action potential duration (APD90), (E)
amplitude (APA), (F) upstroke velocity (dV/dtmax), and (G) atrial effective refractory period (aERP), all measured before and after application of 1 µM [ISO] at a
stimulated rate of 8 Hz. The calculated AP parameters were averaged from 10 consecutive APs before aERP measurements for each experiment. Statistical analysis
was done using a Student’s paired t-test. ∗p < 0.05.
RESULTS
Interrogation of β-adrenergic and muscarinic activation on atrial
APs in isolated right rat atrium was performed based on a newly
developed AF model in isolated rat atria (Skibsbye et al., 2015).
In this model, a high-resistance electrode is impaled into a
single cardiomyocyte in a multicellular tissue, making it possible
to measure transmembrane APs in beating isolated rat atria.
The β-AR agonist ISO (1 µM) and the muscarinic receptor
agonist CCh (1 µM) were used to mimic sympathetic and vagal
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FIGURE 4 | Electrophysiological effects of [CCh]. Diary plots from an experiment, 0–5 min after 1 µM [CCh] was applied, depicting the time dependence of [CCh]
effects on (A) RMP and (B) APD90 as a function of action potentials (APs). The initial to full effect of CCh is abrupt and happens within 100–200 APs. Effect of
muscarinic activation on AP parameters (n = 11): (C) Average of the resting membrane potential (RMP), (D) action potential duration at 90% repolarization (APD90),
(E) action amplitude (APA), (F) maximum upstroke velocity (dV/dtmax), and (G) atrial effective refractory period (aERP), all measured before and after adding 1 µM
CCh. Statistical analysis was done using a Student’s paired t-test. ∗p < 0.05, ∗∗p < 0.005, and ∗∗∗p < 0.001.
activation, respectively. The atria were stimulated at 5 Hz pacing
in all experiments apart from the ISO-treated group which were
stimulated at 8 Hz to overrule the increase in intrinsic beating
frequency. After 30 min of stabilization and a 15 min baseline
period, tissues were randomized to application of ISO, CCh, or
TMC (basal; Figure 1). Following 30 min of application of ISO,
the SK channel inhibitor ICA was added for another 30 min. In
the experiments mimicking vagal activation by the use of CCh,
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FIGURE 5 | Electrophysiological effects of SK channel inhibition with [ICA] on [ISO] pre-stimulated atria (1 µM [ISO], 10 µM [ICA], n = 5). (A) Representative traces of
action potentials. (B) Resting membrane potential (RMP), (C) atrial effective refractory period (aERP), (D) action potential duration at 90% repolarization (APD90), (E)
action potential duration at 50% repolarization (APD50), (F) upstroke velocity (dV/dtmax), and (G) AF duration (s), at pacing rate 8 Hz. The significance level was found
using a two-way ANOVA by comparing the average of 10 consecutive APs before aERP measurements at baseline and after application of drug. ∗p < 0.005 and
∗∗p < 0.01.
the tissue was following the 30 min incubation challenged by
ICA, Fleca, or DMSO (vehicle). aERP was measured by an S1–S2
stimulation protocol at the end of each period in the ISO and CCh
groups. Short burst pacing periods (50 Hz, ∼1000 ms at double
voltage threshold) were applied to evoke runs of arrhythmia
which had a mean duration of ≈10 s. The “basal” group was
conducted to compare the AF duration between non-treated atria
and ISO and CCh treated atria. The remaining of experiments in
this study were devoted to addressing AP parameters, ERP, and
AF and were performed as paired experiments with either ISO or
CCh activated atria including TMC groups.
Examples of runs of AF following control (basal), muscarinic
(CCh), and β-adrenergic (ISO) activation are shown in Figure 2.
Arrhythmias transiently had a high dominant frequency between
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FIGURE 6 | Electrophysiological effects of SK channel inhibition with [ICA] on [CCh] pre-stimulated atria (1 µM [CCh], 10 µM [ICA], n = 12). (A) Representative traces
of action potentials. (B) Resting membrane potential (RMP), (C) atrial effective refractory period (aERP), (D) action potential duration at 90% repolarization (APD90),
(E) action potential duration at 50% repolarization (APD50), (F) upstroke velocity (dV/dtmax), and (G) data on AF duration normalized to baseline (%), at pacing rates
of 5 Hz. The significance level was found using a two-way ANOVA by comparing the average of 10 consecutive APs before each aERP measurement at baseline
and after application of drug or vehicle. ∗p < 0.05, ∗∗p < 0.005, and ∗∗∗p < 0.001.
20 and 40 Hz; however, after a few seconds and especially
during longer AF runs, the frequency declined reaching an
almost steady-state frequency before spontaneous reversion to
SR (Figures 2B,D,F). These observations correspond well with
previous recordings performed in non-stimulated atria (Skibsbye
et al., 2015).
Interestingly, ISO-stimulated atria had significant shorter AF
durations than both control (basal) and CCh activated atria, and
the AF frequency prior to the reversion to SR was significantly
lower in the ISO group. While the CCh activated atria exhibited
AF runs more consistently than in the control group (with
high transient frequencies), the difference in AF duration and
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frequency did not reach statistical significance. During the AF
episodes, the minimum diastolic potential [measured just prior
to the next AP (take-off potential)] was depolarized to≈−65 mV
consistently in all three groups.
Effects of β-Adrenergic Stimulation on
Action Potential Parameters
Isoprenaline application induced a fast increase in intrinsic SR
frequency (from 4.4 to 9.8 Hz, transiently) and stabilizing at
≈7 Hz after a few minutes before stimulated pacing at 8 Hz
was applied (Figures 3A,B). At a fixed pacing frequency of
8 Hz, neither RMP (baseline: −76 ± 1 mV, ISO: −76 ± 1 mV,
p = 0.89, n = 9), APD90 (baseline: 22 ± 3 ms, ISO: 16 ± 1 ms,
p = 0.14, n = 9), aERP (baseline: 27 ± 12 ms, ISO: 24.0 ±
10 ms, p = 0.48, n = 9), upstroke velocity (baseline: 103± 24 V/s,
ISO: 122± 32 V/s, p = 0.11, n = 9), or action potential amplitude
(APA; baseline: 85 ± 7 mV, ISO: 83 ± 5 mV, p = 0.59, n = 9)
were significantly affected by ISO as compared to baseline at 8 Hz
pacing (Figure 3).
Effects of Muscarinic Stimulation on
Action Potential Parameters
Muscarinic activation resulted in drastic alterations in a number
of AP parameters (Figure 4). Following addition of CCh, the
RMP was hyperpolarized by −6 ± 1 mV. This was accompanied
by shortening of APD90 (by 7 ± 2 ms, p = 0.0014, n = 11) and
aERP (by 4 ± 2 ms, p = 0.078, n = 11). The upstroke velocity
(baseline: 130± 38 V/s, CCh: 126± 31 V/s, p = 0.57, n = 11) and
APA (baseline: 88 ± 8 mV, CCh: 89 ± 8 mV p = 0.58, n = 11),
however, were not significantly affected.
As we previously have found that pharmacological inhibition
of SK channels has an antiarrhythmic effect in non-stimulated
isolated rat atria (Skibsbye et al., 2014), we wished to analyze
whether this also was the case in β-adrenergic and muscarinic
stimulated atria. Inhibition of SK channels was accomplished
by applying 10 µM ICA. At this concentration, ICA efficiently
blocks SK channels in multicellular atrial tissue samples, but
does not block other prominent cardiac potassium ion channels
(Skibsbye et al., 2014).
SK Channel Inhibition Prolongs aERP
and APD and Prevents AF During
β-Adrenergic Activation
In ISO-stimulated atria, application of 10 µM ICA, after 30 min,
resulted in a significantly prolonged APD50 (from 7 ± 1
to 10 ± 1 ms, p < 0.01, n = 5) and APD90 (from 17 ± 2 to
29 ± 3 ms, p < 0.01, n = 5) as well as aERP (from 22 ± 5 to
49 ± 9 ms, p < 0.05, n = 5; Figure 5), leading to increased post-
repolarization refractoriness (Coronel et al., 2012). Furthermore,
a reduced upstroke velocity was observed (from 111 ± 14 to
74 ± 12 V/s, p < 0.05). Even though ISO-treated atria were only
susceptible to shorter runs of AF following burst pacing, ICA was
still capable of suppressing the AF burden even further (from
7± 5 to 0.1± 0.1 s, p< 0.5, n = 5, Figure 5G).
SK Channel Inhibition Prolongs aERP
and APD and Prevents AF During
Muscarinic Activation
Block of SK channels with 10 µM ICA in CCh activated atria
resulted in both drastic prolongation of APD (APD90: from
19± 1 to 42± 5 ms, p< 0.0001, n = 6) and aERP (from 17± 2 to
32± 3 ms, p< 0.0001, n = 6; Figure 6). There was a trend to a less
negative RMP (from−78± 1 to−77± 2 mV, p = 0.58, n = 6) and
a reduced upstroke velocity (from 122 ± 6 to 98 ± 11, p = 0.71,
n = 6). AF duration following ICA application was profoundly
reduced (from 10± 7 to 2± 1, p< 0.05, n = 6; Figure 6G).
Flecainide Prolongs aERP and APD and
Prevents AF Under Muscarinic
Stimulation
CCh had significant potentiating effects on AF inducibility
compared to ISO. In order to benchmark the anti-AF effect
of ICA toward a clinically relevant therapy, we applied the
classic antiarrhythmic compound Fleca on CCh activated atria
(Figure 7). Following application of 1 µM Fleca APD90 was
augmented (from 14± 2 to 22± 3 ms, p< 0.005, n = 6) and aERP
(from 15 ± 2 to 29 ± 3 ms, p < 0.001, n = 6), leading to post-
repolarization refractoriness. Upstroke velocity was decreased
from 152 ± 9 to 103 ± 6 mV/s following Fleca application.
Application of Fleca almost completely suppressed any induction
of AF following burst pacing (from 38 ± 15 to 1 ± 1 s,
p< 0.05, n = 6). Antiarrhythmic efficacy (expressed as percentage
shortening of mean AF episodes) was not different between ICA
and flecanide (88 ± 24% vs. 98 ± 41%, n.s. unpaired t-test),
indicating that the two compounds exhibit similar efficacies at
their respective free exposures.
DISCUSSION
β-adrenergic and muscarinic activation of rat right atrium was
investigated to evaluate the changes in electrophysiological
parameters which could affect arrhythmia induction,
maintenance and termination. Following, pharmacological
intervention with ICA and Fleca was performed to address the
antiarrhythmic potential of these compounds targeting primarily
SK channels and Na+ channels, respectively.
Carbachol activation resulted in immediate abbreviations of
APD and aERP, and a hyperpolarized RMP, while no significant
changes, besides increased beating frequency, were observed for
ISO activated atria.
Arrhythmia Duration Following Burst
Pacing
Short runs of AF could be triggered in almost all experiments
following burst pacing for ∼1 s. During arrhythmias, take-
off potential (minimal diastolic potential) prior to the next
upstroke was depolarized to around ≈−65 mV in contrast to
≈−75 mV during SR. This 10 mV shift has profound effect
on Na+ channel availability, due to increased voltage-dependent
inactivation (Petitprez et al., 2008). This effect is observed by
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FIGURE 7 | The effect of flecainide on CCh-pre-stimulated atria (1 µM [CCh], 1 µM [flecainide], n = 12). (A) Representative traces of action potentials. (B) Resting
membrane potential (RMP), (C) atrial effective refractory period (aERP), (D) action potential duration at 90% repolarization (APD90), (E) action potential duration at
50% repolarization (APD50), (F) upstroke velocity (dV/dtmax), with the time-matched control group being unchanged (from 136 ± 12 to 137 ± 22 mV/s) and the
flecainide group being reduced (from 152 ± 9 to 103 ± 6 mV/s), and (G) data on AF duration normalized to baseline (%), at pacing rates of 5 Hz. The significance is
calculated using a two-way ANOVA by comparing the average of 10 consecutive APs before each aERP measurement at baseline and after application of drug or
vehicle. ∗p < 0.05, ∗∗p < 0.005, and ∗∗∗p < 0.001.
a drastic decrease in upstroke velocity, which is expected to
provoke a reduction in conduction velocity (Skibsbye et al.,
2015). ISO activated atria had shorter AF durations compared
to both basal and CCh stimulated atria. The minor increase in
duration and frequency of atrial arrhythmias in CCh activated
atria did not reach significance as compared to non-stimulated
(basal) control atria. Recently, Zafalon et al. (2013), who also
investigated isolated rat atria, found a minor, but significant,
increase in the frequency of atrial tachycardia following CCh
incubation.
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Increase of both sympathetic and vagal activation can
potentially increase the risk of atrial arrhythmias (Chen et al.,
2014; Hou et al., 2016), and in particular induction of arrhythmias
has been found to be promoted by vagal stimulation with ACh
or CCh (Goldberger and Pavelec, 1986; Godoy et al., 1999;
Zafalon et al., 2004; Kirchhoff et al., 2015; Skibsbye et al.,
2015). The changes in electrophysiological parameters during
muscarinic activation lead to opening of the Kir3.1/Kir3.4 channel
complex underlying the IK,ACh current. In concordance with
other studies, we find this to increase phase 3 repolarization,
abbreviation of APD90, hyperpolarization of RMP, and a
dramatic shortening of the aERP (Iijima et al., 1987; Yang
et al., 1996). The CCh induced decrease in ERP will translate
into a shortened wavelength (WL) of excitation propagation,
promoting re-entry arrhythmias (Nattel, 2002; Comtois et al.,
2005; Nattel et al., 2005). This mechanism might explain
why β-adrenergic activation with ISO (where ERP was found
unaltered) showed less effective in promoting AF compared to
muscarinic activation. Our findings are in agreement with Liu
and Nattel (1997) who reported the difference in sympathetic
and vagal effects on AF in dogs, showing that sympathetic
activation did not promote and maintain AF to the same extend
as vagal stimulation, directly comparable with WL shortening.
In addition, the authors showed that vagal, and not sympathetic
activation, abbreviated the atrial refractoriness (Liu and Nattel,
1997).
The cellular effects of CCh are profound, whereas the cellular
effects of isoproterenol are minor. Despite this, at the organ level,
ISO reduced both frequency and duration of AF more than CCh.
This might be an important finding, as it suggests that the changes
of the cellular parameters are not causal for the antiarrhythmic
efficacy.
In the study, we did not detect a significant difference
in AF duration between CCh-treated and non-treated atria.
The reason for this may be explained by the additional effect
of activating IK,Ach, as activation of this current will also,
in addition to shorten APD90 and ERP, shift RMP toward
more hyperpolarized potentials. RMP hyperpolarization releases
a larger fraction of voltage-dependently inactivated sodium
channels, which on one the hand increases cellular excitability,
but on the other hand speeds up tissue conduction velocity,
prolonging the functional WL. This indirect augmented WL
could be speculated to be a reason for CCh treated atria not
translating into more proarrhythmic substrates, as one would
have expected.
SK Channel Inhibition on β-Adrenergic
and Muscarinic Activated Atrium
In order to investigate the effect on activated atria, the SK
channel blocker ICA was applied. SK channel inhibition showed
significant antiarrhythmic effects in this model, both in the
presence of β-adrenergic and muscarinic activators, showing a
prolongation of both APD and aERP. These findings on AP
parameters thereby complement previous studies (Diness et al.,
2010; Skibsbye et al., 2014, 2015; Kirchhoff et al., 2015) providing
further evidence for a mechanistic understanding of SK currents
in AF, where a slowing to the AP repolarization seems to be
a pivotal parameter. It has previously been shown that SK
channel blockers result in depolarization of RMP – suggested
to have indirect inhibitory effects on sodium conductance
due to voltage-dependent inactivation (Skibsbye et al., 2014,
2015). However, the depolarization following application of ICA
trended toward, but did not reach, significant levels in this
study. However, we did observe a reduction in conduction
velocity in the ISO-treated group following ICA application
and a trend toward a reduction in the CCh treated group
following ICA application. Since 10 µM ICA is not expected to
block the cardiac sodium current (Skibsbye et al., 2014), these
results indicate that the slight shift in depolarization of the
RMP affects sodium channel availability and thereby upstroke
velocity.
Interestingly, in the CCh treated atria, SK channel inhibition
demonstrated antiarrhythmic properties with similar efficacy to
the antiarrhythmic class IC drug Fleca. Due to the primary
target of Fleca being Nav1.5, post-repolarization refractoriness
was observed, suggesting this to be the primary driver for the
antiarrhythmic efficacy representing a classic class IC AAD.
In the same setting, ICA application caused extensive APD
prolongation exceeding tissue refractoriness, here representing a
more classical Class III AAD. The antiarrhythmic effects reported
here highlight the possibility of SK channel inhibition as being
efficacious also in clinical AF.
Limitations
Sympathetic and vagal activation was limited to pharmacological
interventions in the isolated atria, since vagal and sympathetic
nerve innervation are blunted. ISO stimulation makes the atria
contract much more rigorously. Maintaining proper sealing
to the cardiomyocytes thereby becomes challenging, resulting
in a low success-rate with ISO (≈20%). Due to this limited
number of achievable experiments with ISO, it was decided
only to benchmark Fleca vs. ICA efficacy in the setting of vagal
stimulation. All experiments apart from the groups treated with
ISO were performed at a pacing frequency of 5 Hz in order to
overcome the atrial sinus frequency. As ISO treatment increases
the beating frequency, these experiments were performed at
8 Hz. Comparison between these groups should therefore be
done with caution as frequency is an important parameter
in regulating AP morphology and arrhythmogenesis. None of
the AADs tested in this model are absolute selective for their
primary target at the concentrations tested in this study. The
sodium-channel blocker Fleca and the SK channel blocker ICA
are promiscuous and inhibit, e.g., other potassium channels
to some extent. Therefore, it is likely that the antiarrhythmic
effects, including the effects on conduction velocity, observed
to some degree reflect the inhibitory effects of multiple
targets.
CONCLUSION
Vagal activation with CCh leads to shortening of atrial
APD and ERP and hyperpolarization of RMP compared to
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control atria. β-adrenergic activated atria did not alter AP
parameters compared to control but resulted in reduced
arrhythmia duration and frequency. In vagally stimulated
atria, pharmacological inhibition of SK channels by ICA
demonstrates similar antiarrhythmic efficacy to the sodium
channel inhibitor Fleca with both compounds prolonging the
APD and aERP. Furthermore, SK channel inhibition reduced
the duration of arrhythmia in β-adrenergic activated atria,
altogether demonstrating this as an interesting antiarrhythmic
target in variable autonomic imbalanced scenarios. The possible
clinical implication of SK blockers for the treatment of AF
in hyper-vagal and hyper-sympathetic patients calls for further
investigation.
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